1 / 1

Figure S1

Figure S1. (PI). Phosphatidylinositol 3-kinase. Phosphatidylinositol 4-phosphate 3-kinase.

lena
Download Presentation

Figure S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure S1 (PI) Phosphatidylinositol 3-kinase Phosphatidylinositol 4-phosphate 3-kinase Figure S1. Differences in the phosphatidyl inositol pathway between catch-up and non-catch-up SGA children identified by integrated analysis of transcriptomic and metabolomic data. Metabolic changes included myo-inositol (urine GC-MS, p<0.04, -4.0 fold CU v NCU), phosphatidyl inositol (serum UPLC-MS, p<0.05, 1.5 fold) & 1-Phosphatidyl-1D-myo-inositol 3-phosphate (serum UPLC-MS, p<0.02, 1.5 fold). Gene expression changes included an increase in PTPN11 (p<0.01) as part of the Phosphatidylinositol 3-kinase enzyme complex (EC 2.7.1.137) and a decrease in PIK3C3 & PIK3C2A (p<0.05) as part of the Phosphatidylinositol-4-phosphate-3-kinase enzyme complex (EC 2.7.1.154). Rounded rectangles = molecules identified by metabolomics; double-lined ovals = enzyme complexes identified by gene expression. All fold changes are CU/NCU SGA, green = decreased expression, red = increased expression.

More Related